Arrowstreet Capital Limited Partnership Has $19.93 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

Arrowstreet Capital Limited Partnership decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 40.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 148,336 shares of the medical research company's stock after selling 100,640 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.05% of Agilent Technologies worth $19,927,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the company. Allstate Corp acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $1,144,000. Brown Brothers Harriman & Co. increased its holdings in Agilent Technologies by 59.9% in the fourth quarter. Brown Brothers Harriman & Co. now owns 1,033 shares of the medical research company's stock valued at $139,000 after purchasing an additional 387 shares during the last quarter. DnB Asset Management AS lifted its stake in Agilent Technologies by 1.5% in the fourth quarter. DnB Asset Management AS now owns 51,014 shares of the medical research company's stock valued at $6,853,000 after buying an additional 741 shares during the period. Orion Portfolio Solutions LLC boosted its holdings in Agilent Technologies by 8.2% during the fourth quarter. Orion Portfolio Solutions LLC now owns 9,209 shares of the medical research company's stock worth $1,237,000 after buying an additional 696 shares during the last quarter. Finally, denkapparat Operations GmbH acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $284,000.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Bank of America cut their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a report on Friday, December 13th. StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Wells Fargo & Company lowered their price target on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a report on Monday, December 9th. Robert W. Baird cut their price objective on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. Finally, Citigroup increased their target price on Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research note on Thursday, December 19th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $150.83.

Remove Ads

Agilent Technologies Stock Down 4.5 %

Shares of Agilent Technologies stock traded down $4.62 during trading hours on Tuesday, reaching $98.97. 4,525,087 shares of the company's stock were exchanged, compared to its average volume of 1,818,160. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The company has a 50 day moving average of $127.40 and a two-hundred day moving average of $134.90. The stock has a market cap of $28.22 billion, a P/E ratio of 22.75, a P/E/G ratio of 2.89 and a beta of 1.19. Agilent Technologies, Inc. has a fifty-two week low of $97.37 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 1.00%. Agilent Technologies's dividend payout ratio is presently 22.76%.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company's stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,638 shares of company stock valued at $731,229.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.